Related Experiment Videos
Radiation therapy for breast cancer
1Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Current Opinion in Oncology
|November 1, 1995
Summary
This study examines late effects in radiation oncology, focusing on dose, volume, and boost dose importance. It also addresses patient risk factors, elderly care, axillary dissection, and tamoxifen
Area of Science:
- Radiation Oncology
- Clinical Oncology
Background:
- Maturing databases allow for in-depth analysis of treatment outcomes.
- Minimizing late effects of radiation therapy is a key clinical goal.
Purpose of the Study:
- To re-examine the role of boost dose in radiation therapy.
- To analyze patient risk factors and tailor management strategies.
- To address the specific needs of elderly patients, including axillary dissection and tamoxifen use.
Main Methods:
- Literature review of recent analyses on late dose and volume effects.
- Examination of sophisticated margin information from pathology.
- Analysis of patient stratification by risk factors.
- Focus on elderly patient considerations and tamoxifen efficacy.
Main Results:
- Emerging literature highlights dose and volume effects, and second cancer risks.
- Boost dose reevaluation is crucial with advanced margin data.
- Patient grouping by risk factors is replacing standard stage-based management.
- Elderly patients require specific considerations for axillary dissection and tamoxifen.
Conclusions:
- Optimizing radiation therapy requires detailed analysis of late effects.
- Personalized treatment based on risk factors and patient subgroups is advancing.
- Special attention to elderly patients and hormonal therapy is essential for improved outcomes.